HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,877,000 | -3.7% | 150,220 | 0.0% | 0.58% | -16.3% |
| Q2 2020 | $4,027,000 | +49.0% | 150,220 | 0.0% | 0.70% | +31.2% |
| Q1 2020 | $2,702,000 | +1.6% | 150,220 | +0.1% | 0.53% | +15.2% |
| Q4 2019 | $2,660,000 | -27.5% | 150,000 | -36.6% | 0.46% | -34.1% |
| Q3 2019 | $3,669,000 | -9.7% | 236,540 | 0.0% | 0.70% | -11.0% |
| Q2 2019 | $4,064,000 | +6.7% | 236,540 | 0.0% | 0.79% | -0.8% |
| Q1 2019 | $3,808,000 | +10.0% | 236,540 | 0.0% | 0.79% | -5.6% |
| Q4 2018 | $3,461,000 | – | 236,540 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |